Arxada extends partnership with DSM and invests in Visp, Switzerland, facility

• Arxada to invest CHF 20m in the growth of the Visp facility and commits to reducing the site’s carbon footprint

Basel, Switzerland – 24 August 2022 –  Arxada, a global leader in specialty chemicals, today announces the extension of its long-term collaboration with Royal DSM (DSM), a global science-based company, for the supply of niacin and a range of other nutritional ingredients from Arxada’s facility in Visp, Switzerland, to DSM’s vitamin and aroma ingredients business in neighboring Visp-Lalden. 

As part of this long-term partnership extension with DSM, Arxada will invest CHF 20m in its world-class production facility in Visp. This investment will be used to expand production lines at the site and increase Arxada’s output of nutritional ingredients supplied to DSM.

Arxada will also make further investments to reduce the carbon footprint of the Visp site to help meet the sustainability commitments of both companies. This follows Arxada’s significant investment in Visp in 2021 to reduce other greenhouse gas emissions at the site.

Antje Gerber, President, Specialty Products Solutions, Arxada, said:
“We are delighted to be extending our agreement with DSM and building on the longstanding, mutually beneficial partnership with our neighbors in the Swiss Valais canton. This significant new investment in our Visp facility secures the site’s long-term future, helping to fuel our future growth, and demonstrates our clear commitment to sustainability and reducing our carbon footprint.”

– ENDS – 

 

Media Enquires

Arxada
Birgit Gronkowski,
Head of Communications
Tel: +41 61 316 8111
Email: birgit.gronkowski@arxada.com  

FTI Consulting
Rob Winder/Amy Byrne
Tel: +44 20 3727 1000
Email: Arxada@fticonsulting.com    

 

About Arxada
Arxada is a global specialty chemicals business with a world-class offering in Consumer Microbial Control (CMC), Industrial Microbial Control (IMC) and Specialty Products Solutions (SPS). Arxada provides a broad portfolio of differentiated products targeted at a range of end markets, supported by its leading regulatory capabilities, IP expertise and established track record in R&D.

Arxada’s CMC business targets five end markets: Hygiene, Home and Personal Care, Wood Protection, Crop Protection, and Food, Beverage and Water, while IMC focuses on Paints and Coatings and Material Protection. Both businesses build on superior regulatory expertise, the broadest set of antimicrobial agents and the widest range of registrations in the world, which are critical to maintaining the integrity of their customers’ products.

SPS provides complex, high-quality technologies and chemistries to customers across a range of industries within its three business lines: Performance Intermediates and Chemicals, Composite Materials and the Custom Development and Manufacturing Organization.

The three businesses work closely together to provide complementary expertise and deliver unique, innovative solutions to help customers protect their products from harmful microorganisms, improve health and safety and reduce their environmental footprints.

Arxada has a global footprint spanning 26 production sites and 17 R&D centers, with a world-leading team of 3,800 employees serving customers across a wide range of industries.

Arxada, formerly part of Lonza Group, is owned by Bain Capital Private Equity and Cinven.

To learn more about Arxada, please visit: arxada.com and Arxada on LinkedIn.